Cite
HARVARD Citation
Sakellariou, G. et al. (2016). Long‐term administration of the mitochondria‐targeted antioxidant mitoquinone mesylate fails to attenuate age‐related oxidative damage or rescue the loss of muscle mass and function associated with aging of skeletal muscle. FASEB journal. 30 (11), pp. 3771-3785. [Online].